TONIGHT! the ACR is holding a " Just Diagnosed: Now What? Patient Webinar" - this will feature Academy-nominated screenwriter & patient Emily Gordon ("The Big Sick") with Rheumatologist Stuart Kassan, MD, register here: https://t.co/TOCgOuV0Ng

Analysis of 508 #RA pts (over 10 yrs) in the BeST study shows joint swelling at baseline resulted in half w/ re-swelling later and significantly increased risk of same joint swelling during follow-up (OR 2.37, 95% CI 2.30 to 2.43, p<0.001) https://t.co/a7zH4YRAkq

PROCEED study of 300 pts with chronic, DXA proven bone loss in half (osteopenia in 39% and osteoporosis in 17%) with higher fracture rates. Such pts should undergo screening for osteoporosis. https://t.co/7fgeAk85vu

U.S. Preventive Services Task Force (USPSTF) reaffirmed its recommendations that pregnant women at a high risk of preeclampsia should take a daily aspirin regimen at the end of the first trimester https://t.co/DiV7p6g8vL

Finnish Pop study 939 #RA pts shows highest healthcare costs linked to high Dz activity & comorbidity. Clusters: C1) young w/ low costs & activity, C2) chronic pain, disability, fatigue, C3) high cost/dz activity, less pain, C4)comorbidities w/ $$$ https://t.co/Azc35zyA9J

RA DMARD use gleened from 86 rheumatologists recording Rx choices/reasons on next 12 pts. Total: 1027 RA pts, 621 already on b/ or tsDMARD (68% TNFi, 21% JAKi). ~Half who switched given another TNFi . Reasons: LOE, dz worsening https://t.co/zpjSO25wsh

EULAR has received reports of tocilizumab shortage in several countries, including Germany, Portugal, Belgium, and Scandinavia. The UK and France are aware tocilizumab concerns, but have not yet reported actual shortages https://t.co/7QpjZTXXAK

DEA has warned of an increase in illegal counterfeit pills containing fentanyl & methamphetamine. These often look Rx opioids (Oxycontin, Percocet, Vicodin), Xanax or Adderall. DEA seized >9.5 million fake pills (more than last 2 yrs) https://t.co/Y0gJ4XrV1a

Study Finds U.S. Generic and Biosimilar Savings Totaled a Record $338 Billion in 2020 https://t.co/hPR0nGd6jp

Biosimilar update: 31 FDA approved biosimilars, but only 60% made it to market. 2015 to 2019, drug spending grew 6.1%, biologic spending grew 14.6%; biologics are 43% of US drug spending. Most biologics at ~30% discount. https://t.co/4paYH8yVLQ